Angene Chemical
Draw
|
Currency :
Home Products

AG019FT8

102625-70-7 | Pantoprazole

Chemical structure of Pantoprazole, CAS 102625-70-7
AG019FT8
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 102625-70-7
Catalog Number AG019FT8(AGN-PC-00PUH8)
Chemical Name Pantoprazole
EC Number 600-331-6
IUPAC Name 6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole
InChI InChI=1S/C16H15F2N3O4S/c1-23-13-5-6-19-12(14(13)24-2)8-26(22)16-20-10-4-3-9(25-15(17)18)7-11(10)21-16/h3-7,15H,8H2,1-2H3,(H,20,21)
InChI Key IQPSEEYGBUAQFF-UHFFFAOYSA-N
MDL Number MFCD00870182
Molecular Formula C16H15F2N3O4S
Molecular Weight 383.3698
NSC Number 759257
SMILES O=S(C1=NC2=CC=C(OC(F)F)C=C2N1)CC3=NC=CC(OC)=C3OC
Synonyms
BY 1023, BY-1023, BY1023, pantoprazole, pantoprazole sodium, Protonix, SK and F 96022, SK and F-96022, SK and F96022, SKF 96022, SKF-96022, SKF96022, pantoprazole, 102625-70-7, Protonix, Pantozol, Pantoprazolum, Pantoprazol, BY-1023, Pantoloc, Pantoprazol [INN-Spanish], Pantoprazolum [INN-Latin], SK&F-96022, BY 1023, Protonix I.V., Protonix IV, SK&F 96022, Protium, C16H15F2N3O4S, Pantozol Control, SK-96022, HSDB 7292, CHEMBL1502, CHEBI:7915, Pantoprazole sodium hydrate, 5-(Difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridyl)methyl)sulfinyl)benzimidazole, 5-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole, NCGC00095188-01, UNII-SX78SGO2TV, DSSTox_CID_3416, Controloc Control, 1H-Benzimidazole, 5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-, DSSTox_RID_77019, DSSTox_GSID_23416, Pantoprozole, Astropan, Panyocid, Zosecta, Pantor, L-Pantoprazole, Pantoprazole Na, apo-Pantoprazole, Somac Control, Pantecta Control, Pantoloc Control, 6-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1H-benzimidazole, Pantoprazole, S-, (-)-Pantoprazole, CAS-102625-70-7, Pantoprazole [USAN:BAN:INN], SX78SGO2TV, S-(-)-Pantoprazole, SKF-96022, Pantoprazole (USAN/INN), Pantoprazole [USAN:INN:BAN], 1H-Benzimidazole, 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, 5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole, SKF96022, pantoprazole-protonix, Pantoprazole (Protonix), Pantoprazole-d6 (Rac), AC1L1IPJ, EC 600-331-6, SCHEMBL29465, BSPBio_002320, MLS003882559, BIDD:GT0003, SPECTRUM1505818, GTPL7260, DTXSID4023416, CTK8E8734, IQPSEEYGBUAQFF-UHFFFAOYSA-N, HMS1922H20, HMS2090H03, HMS2093F14, Pharmakon1600-01505818, BCP21400, Tox21_111477, AC-679, BDBM50241342, MFCD00870182, NSC759257, s2105, STL451032, AKOS015894910, AKOS034831879, Tox21_111477_1, CCG-213558, CS-3161, DB00213, MCULE-8988409059, NSC-759257, SB17368, 1H-Benzimidazole, 6-(difluoromethoxy)-2-((S)-((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-, 5-(difluoromethoxy)-2-((3,4-dimethoxypyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole, 6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole, NCGC00095188-02, NCGC00095188-03, NCGC00095188-04, NCGC00095188-05, 142678-35-1, AN-15599, BC203892, HY-17507, LS-32883, SMR002533625, SBI-0206873.P001, AB0012612, AB2000509, RT-014935, TL8000127, B4720, FT-0602547, C11806, D05353, W-1227, AB01275513-01, AB01275513_02, 625P707, A800593, SR-01000763715, I06-0068, J-000744, SR-01000763715-3, 5-(difluoromethoxy)-2-((3,4-dimethoxypyridin-2-yl), BRD-A22380646-001-01-5, BRD-A22380646-001-02-3, 2-(((3,4-Dimethoxy-2-pyridinyl)methyl)-sulfinyl)-5-methyl-1H-1,3-benzimidazole, 5-(difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole, 5-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1H-benzimidazole, 5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methanesulfinyl]-3H-1,3-benzodiazole, 5-Difluoromethoxy-2-(3,4-dimethoxy-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole, 5-DifluoroMethoxy-2-[(3,4-diMethoxy-2-pyridinyl)Methyl-sulfinyl]-1H-benziMidazole, 5-Difluoromethoxy-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1H-benzimidazole, 6-(difluoromethoxy)-2-((3,4-dimethoxypyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole, 6-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridinyl)methylsulfinyl]-1H-benzimidazole, 6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methanesulfinyl]-1H-1,3-benzodiazole, 6-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methane]sulfinyl}-1H-1,3-benzodiazole, 6-[bis(fluoranyl)methoxy]-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole, 5-(DIFLUOROMETHOXY)-2-[[(3,4-DIMETHOXY-2-PYRIDINYL)METHYL]SULFINYL]-1H-BENZIMIDAZOLE(Sodium salt form), Pantoprazole Sodium, Somac, Controloc, Pantecta, Pantopan, Zurcal, Protonix DR, Controloc (TN), Astropan (TN), Pantecta (TN), Pantoloc (TN), Pantopan (TN), Pantotab (TN), Pantozol (TN), Protonix (TN), Ulcepraz (TN), Inipomp (TN), Protium (TN), Pantor (TN), Somac (TN), Protonix delayed-release, UNII-D8TST4O562, D0T6XX, Pantoprazole Sodium [USAN], C16H15F2N3O4S.Na, PANTOPRAZOLE SODIUM SALT, D8TST4O562, Pantoprazole sodium sesquihydrate, UNII-S9363155XL, CID4679, BY1023, methylsulfinyl)-1H-benzo[d]imidazole, SK&F96022, SKF 96022, CS-O-10995, C16-H15-F2-N3-O4-S, C16-H15-F2-N3-O4-S.Na, 1637A, C064276, D000077402, 138786-67-1, (S)-6-(difluoromethoxy)-2-((3,4-dimethoxypyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole, 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1h-benzimidazole, 102625-64-9, 1H-Benzimidazole, 6-(difluoromethoxy)-2-[(S)-[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, 5-(Difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole sodium, na,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited